Medable Inc. - Company Research Report

Company Overview

• Name: Medable Inc.

• Mission: Medable is on a mission to enable effective therapies to people faster by transforming the clinical trial process with a patient-centric approach, leveraging innovation and technology.

• Founded: Medable was founded by Dr. Michelle Longmire.

• Key People:

• Dr. Michelle Longmire - CEO and co-founder

• Tim Smith - Chief Technology Officer and co-founder

• Andrew Mackinnon and Jessica Dolphi - Notable contributors in solution consulting and platform development

• Headquarters: Medable is headquartered in Palo Alto, California.

• Number of Employees: No information is available.

• Revenue: Medable reported 80% revenue growth from portfolio-level eCOA adoption in 2024.

• Known For: Medable is recognized for its advanced digital clinical trial platform, enhancing speed, scale, and patient access in clinical research. It is awarded Best Digital Health Solution by the Galien Foundation.

Products

• Medable Studio

• Description: An all-in-one application for configuring, translating, validating, and launching eCOA Plus (eCOA, eConsent, Televisit, Sensors) into clinical trials.

• Key Features:

• Point-and-Click Builder: Simplifies creation of assessments, instruments, and diaries.

• Visual Schedule of Assessments Builder: Streamlines study scheduling and notifications.

• Translation Workbench: Manages translations to reduce bottlenecks.

• Content Library: Stores assessments, instruments, translations for easy reuse.

• eCOA+ (Electronic Clinical Outcome Assessment)

• Description: A platform for accurate, real-time patient-reported data collection.

• Key Features:

• Streamlined Data Collection: Reduces study build time by 35x.

• Participant Engagement: Enhances inclusivity and accessibility.

• Digital Measures: Standardized integrations for sensors capturing physiological data.

• Total Consent Management

• Description: A comprehensive consent management system for clinical trials.

• Key Features:

• Global Access: Available in 60 countries and 115+ languages.

• eConsent Functionality: Includes support for both digital and wet-ink signatures.

• Compliance and Retention: Real-time notifications and monitoring ensure compliance.

Recent Developments

• New Product Launch: The introduction of Medable Studio, offering unprecedented control over clinical trial processes with a focus on speed and scalability.

• Partnerships:

• Google Cloud Collaboration: Medable announced a strategic alliance with Google Cloud to enhance their platform's capabilities, offering benefits like consolidated billing and streamlined deployment on Google Cloud Marketplace.

• Updates and Features:

• The release of new AI capabilities in Medable Studio to simplify digital clinical trial launches by instantly generating eCOA.

• Launch of Total Consent, showing impressive adoption rates in collaborations, such as the U.S. Renal Care study.

Conclusion

Medable Inc. is recognized as a pioneer in the digital transformation of clinical trials, focusing on enhancing the patient experience and increasing the efficiency of research processes. With robust solutions like Medable Studio and a strategic partnership with Google Cloud, Medable continues to position itself at the forefront of decentralized clinical trials. Its innovative approaches have resulted in significant revenue growth and global recognition, reinforcing its mission to expedite effective therapies to patients worldwide.